142 related articles for article (PubMed ID: 14520657)
21. [Oligoclonal IgG and IgA in subacute sclerosing panencephalitis].
Grimaldi LM; Maimone D; Grasso AA; Pennisi G; Nicoletti F
Acta Neurol (Napoli); 1986 Jun; 8(3):226-9. PubMed ID: 3739769
[No Abstract] [Full Text] [Related]
22. Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases.
Rondaan C; de Haan A; Horst G; Hempel JC; van Leer C; Bos NA; van Assen S; Bijl M; Westra J
Arthritis Rheumatol; 2014 Nov; 66(11):3122-8. PubMed ID: 25223407
[TBL] [Abstract][Full Text] [Related]
23. A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid.
Kneitz RH; Schubert J; Tollmann F; Zens W; Hedman K; Weissbrich B
BMC Infect Dis; 2004 Sep; 4():33. PubMed ID: 15355548
[TBL] [Abstract][Full Text] [Related]
24. Hypothesis: multiple sclerosis cerebrospinal fluid IgG multiple bands are derived from one or a few IgG secretor cell clones.
Tourtellotte WW; Shapshak P; Staugaitis SM; Saxton RE
Prog Clin Biol Res; 1984; 146():371-8. PubMed ID: 6718429
[TBL] [Abstract][Full Text] [Related]
25. A screening assay to detect antigen-specific antibodies within cerebrospinal fluid.
Morris P; Davies NW; Keir G
J Immunol Methods; 2006 Apr; 311(1-2):81-6. PubMed ID: 16530215
[TBL] [Abstract][Full Text] [Related]
26. Varicella-Zoster Virus Vasculopathy: The Growing Association Between Herpes Zoster and Strokes.
Powell DR; Patel S; Franco-Paredes C
Am J Med Sci; 2015 Sep; 350(3):243-5. PubMed ID: 25211583
[TBL] [Abstract][Full Text] [Related]
27. Identification of viral antigens recognized by ocular infiltrating T cells from patients with varicella zoster virus-induced uveitis.
Milikan JC; Kinchington PR; Baarsma GS; Kuijpers RW; Osterhaus AD; Verjans GM
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3689-97. PubMed ID: 17652740
[TBL] [Abstract][Full Text] [Related]
28. Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literature.
Haug A; Mahalingam R; Cohrs RJ; Schmid DS; Corboy JR; Gilden D
J Neurol Sci; 2010 May; 292(1-2):85-8. PubMed ID: 20170926
[TBL] [Abstract][Full Text] [Related]
29. Zoster encephalitis. Isolation of virus and measurement of varicella-zoster-specific antibodies in cerebrospinal fluid.
Andiman WA; White-Greenwald M; Tinghitella T
Am J Med; 1982 Nov; 73(5):769-72. PubMed ID: 6291390
[TBL] [Abstract][Full Text] [Related]
30. [Detection of active varicella-zoster virus (VZV) infection in patients with neurological complications].
Roubalová K; Suchánková A; Bojar M; Glosová L; Machová H; Soltysová K
Klin Mikrobiol Infekc Lek; 2007 Jun; 13(3):109-14. PubMed ID: 17703403
[TBL] [Abstract][Full Text] [Related]
31. Cerebrospinal fluid oligoclonal IgG bands in patients with spinal arteriovenous malformation and structural central nervous system lesions.
Cohen O; Biran I; Steiner I
Arch Neurol; 2000 Apr; 57(4):553-7. PubMed ID: 10768631
[TBL] [Abstract][Full Text] [Related]
32. Allotype analysis to distinguish the origin of varicella-zoster virus immunoglobulin G after allogeneic stem cell transplantation.
Yamazaki R; Nakasone H; Tanaka Y; Sato M; Terasako K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Machishima T; Kimura S; Kikuchi M; Okuda S; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1013-20. PubMed ID: 23583826
[TBL] [Abstract][Full Text] [Related]
33. Clinical features, outcomes, and cerebrospinal fluid findings in adult patients with central nervous system (CNS) infections caused by varicella-zoster virus: comparison with enterovirus CNS infections.
Hong HL; Lee EM; Sung H; Kang JK; Lee SA; Choi SH
J Med Virol; 2014 Dec; 86(12):2049-54. PubMed ID: 24532558
[TBL] [Abstract][Full Text] [Related]
34. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.
Sauerbrei A; Wutzler P
J Clin Microbiol; 2006 Sep; 44(9):3094-7. PubMed ID: 16954232
[TBL] [Abstract][Full Text] [Related]
35. CSF oligoclonal banding pattern changes in a long-surviving SSPE patient treated with alpha-IFN.
Grimaldi LM; Martino GV
Ital J Neurol Sci; 1991 Apr; 12(2):187-91. PubMed ID: 2071365
[TBL] [Abstract][Full Text] [Related]
36. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection.
Schub D; Janssen E; Leyking S; Sester U; Assmann G; Hennes P; Smola S; Vogt T; Rohrer T; Sester M; Schmidt T
J Infect Dis; 2015 Feb; 211(4):600-12. PubMed ID: 25180236
[TBL] [Abstract][Full Text] [Related]
37. Virological course of herpes zoster in otherwise normal hosts.
Cevenini R; Donati M; Rumpianesi F; Moroni A; Tosti A; Patrizi A; Varotti C; Negosanti M
J Med Microbiol; 1983 Aug; 16(3):303-8. PubMed ID: 6308258
[TBL] [Abstract][Full Text] [Related]
38. Serological detection of specific IgG to varicella-zoster virus by novel ELISA based on viral glycoprotein antigen.
Sauerbrei A; Wutzler P
Clin Lab; 2009; 55(1-2):1-7. PubMed ID: 19350844
[TBL] [Abstract][Full Text] [Related]
39. MS and clinically isolated syndromes: shared specificity but diverging clonal patterns of virus-specific IgG antibodies produced in vivo and by CSF B cells in vitro.
Skorstad G; Vandvik B; Vartdal F; Holmøy T
Eur J Neurol; 2009 Oct; 16(10):1124-9. PubMed ID: 19469834
[TBL] [Abstract][Full Text] [Related]
40. Varicella-zoster virus antigen expression of eccrine gland and duct epithelium in herpes zoster lesions.
Horie C; Mizukawa Y; Yamazaki Y; Shiohara T
Br J Dermatol; 2011 Oct; 165(4):802-7. PubMed ID: 21692762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
